Breast Cancer, Version 4.2023 Featured Updates to the NCCN Guidelines

William J. Gradishar; Meena S. Moran; Jame Abraham; Vandana Abramson; Rebecca Aft; Doreen Agnese; H. Allison Kimberly; Bethany Anderson; Harold J. Burstein; Helen Chew; Chau Dang; Anthony D. Elias; Sharon H. Giordano; Matthew P. Goetz; Lori J. Goldstein; Sara A. Hurvitz; Rachel C. Jankowitz; Sara H. Javid; Jairam Krishnamurthy; A. Marilyn Leitch; Janice Lyons; Joanne Mortimer; Sameer A. Patel; Lori J. Pierce; Laura H. Rosenberger; Hope S. Rugo; Bryan Schneider; Mary Lou Smith; Hatem Soliman; Erica M. Stringer-Reasor; Melinda L. Telli; Mei Wei Md; Kari B. Wisinski; Jessica S. Young; Kay Yeung; Mary A. Dwyer; Rashmi Kumar

doi:10.6004/jnccn.2023.0031

Breast Cancer, Version 4.2023 Featured Updates to the NCCN Guidelines

William J. Gradishar, Meena S. Moran, Jame Abraham, Vandana Abramson, Rebecca Aft, Doreen Agnese, H. Allison Kimberly, Bethany Anderson, Harold J. Burstein, Helen Chew, Chau Dang, Anthony D. Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Sara A. Hurvitz, Rachel C. Jankowitz, Sara H. Javid, Jairam Krishnamurthy, A. Marilyn LeitchJanice Lyons, Joanne Mortimer, Sameer A. Patel, Lori J. Pierce, Laura H. Rosenberger, Hope S. Rugo, Bryan Schneider, Mary Lou Smith, Hatem Soliman, Erica M. Stringer-Reasor, Melinda L. Telli, Mei Wei Md, Kari B. Wisinski, Jessica S. Young, Kay Yeung, Mary A. Dwyer, Rashmi Kumar

Medical Oncology

Research output: Contribution to journal › Article › peer-review

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number of treatment options, if one option fails, there is usually another line of therapy available, providing meaningful improvements in survival. This NCCN Guidelines Insights report focuses on recent updates specific to systemic therapy recommendations for patients with stage IV (M1) disease.

Original language	English (US)
Pages (from-to)	594-608
Number of pages	15
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	21
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2023.0031
State	Published - Jun 2023

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2023.0031

Cite this

Gradishar, W. J., Moran, M. S., Abraham, J., Abramson, V., Aft, R., Agnese, D., Kimberly, H. A., Anderson, B., Burstein, H. J., Chew, H., Dang, C., Elias, A. D., Giordano, S. H., Goetz, M. P., Goldstein, L. J., Hurvitz, S. A., Jankowitz, R. C., Javid, S. H., Krishnamurthy, J., ... Kumar, R. (2023). Breast Cancer, Version 4.2023 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 21(6), 594-608. https://doi.org/10.6004/jnccn.2023.0031

Gradishar, WJ, Moran, MS, Abraham, J, Abramson, V, Aft, R, Agnese, D, Kimberly, HA, Anderson, B, Burstein, HJ, Chew, H, Dang, C, Elias, AD, Giordano, SH, Goetz, MP, Goldstein, LJ, Hurvitz, SA, Jankowitz, RC, Javid, SH, Krishnamurthy, J, Marilyn Leitch, A, Lyons, J, Mortimer, J, Patel, SA, Pierce, LJ, Rosenberger, LH, Rugo, HS, Schneider, B, Smith, ML, Soliman, H, Stringer-Reasor, EM, Telli, ML, Md, MW, Wisinski, KB, Young, JS, Yeung, K, Dwyer, MA & Kumar, R 2023, 'Breast Cancer, Version 4.2023 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 21, no. 6, pp. 594-608. https://doi.org/10.6004/jnccn.2023.0031

@article{a322178d491b4625b95e18c833116aa4,

title = "Breast Cancer, Version 4.2023 Featured Updates to the NCCN Guidelines",

abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number of treatment options, if one option fails, there is usually another line of therapy available, providing meaningful improvements in survival. This NCCN Guidelines Insights report focuses on recent updates specific to systemic therapy recommendations for patients with stage IV (M1) disease.",

author = "Gradishar, {William J.} and Moran, {Meena S.} and Jame Abraham and Vandana Abramson and Rebecca Aft and Doreen Agnese and Kimberly, {H. Allison} and Bethany Anderson and Burstein, {Harold J.} and Helen Chew and Chau Dang and Elias, {Anthony D.} and Giordano, {Sharon H.} and Goetz, {Matthew P.} and Goldstein, {Lori J.} and Hurvitz, {Sara A.} and Jankowitz, {Rachel C.} and Javid, {Sara H.} and Jairam Krishnamurthy and {Marilyn Leitch}, A. and Janice Lyons and Joanne Mortimer and Patel, {Sameer A.} and Pierce, {Lori J.} and Rosenberger, {Laura H.} and Rugo, {Hope S.} and Bryan Schneider and Smith, {Mary Lou} and Hatem Soliman and Stringer-Reasor, {Erica M.} and Telli, {Melinda L.} and Md, {Mei Wei} and Wisinski, {Kari B.} and Young, {Jessica S.} and Kay Yeung and Dwyer, {Mary A.} and Rashmi Kumar",

year = "2023",

month = jun,

doi = "10.6004/jnccn.2023.0031",

language = "English (US)",

volume = "21",

pages = "594--608",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "6",

}

TY - JOUR

T1 - Breast Cancer, Version 4.2023 Featured Updates to the NCCN Guidelines

AU - Gradishar, William J.

AU - Moran, Meena S.

AU - Abraham, Jame

AU - Abramson, Vandana

AU - Aft, Rebecca

AU - Agnese, Doreen

AU - Kimberly, H. Allison

AU - Anderson, Bethany

AU - Burstein, Harold J.

AU - Chew, Helen

AU - Dang, Chau

AU - Elias, Anthony D.

AU - Giordano, Sharon H.

AU - Goetz, Matthew P.

AU - Goldstein, Lori J.

AU - Hurvitz, Sara A.

AU - Jankowitz, Rachel C.

AU - Javid, Sara H.

AU - Krishnamurthy, Jairam

AU - Marilyn Leitch, A.

AU - Lyons, Janice

AU - Mortimer, Joanne

AU - Patel, Sameer A.

AU - Pierce, Lori J.

AU - Rosenberger, Laura H.

AU - Rugo, Hope S.

AU - Schneider, Bryan

AU - Smith, Mary Lou

AU - Soliman, Hatem

AU - Stringer-Reasor, Erica M.

AU - Telli, Melinda L.

AU - Md, Mei Wei

AU - Wisinski, Kari B.

AU - Young, Jessica S.

AU - Yeung, Kay

AU - Dwyer, Mary A.

AU - Kumar, Rashmi

PY - 2023/6

Y1 - 2023/6

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number of treatment options, if one option fails, there is usually another line of therapy available, providing meaningful improvements in survival. This NCCN Guidelines Insights report focuses on recent updates specific to systemic therapy recommendations for patients with stage IV (M1) disease.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number of treatment options, if one option fails, there is usually another line of therapy available, providing meaningful improvements in survival. This NCCN Guidelines Insights report focuses on recent updates specific to systemic therapy recommendations for patients with stage IV (M1) disease.

UR - http://www.scopus.com/inward/record.url?scp=85163165333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85163165333&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2023.0031

DO - 10.6004/jnccn.2023.0031

M3 - Article

C2 - 37308117

AN - SCOPUS:85163165333

SN - 1540-1405

VL - 21

SP - 594

EP - 608

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Breast Cancer, Version 4.2023 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this